Drugplain

NDC 17772-133-07

QELBREE 200 mg/1

viloxazine hydrochloride · CAPSULE, EXTENDED RELEASE

No Recall History

QELBREE is a capsule, extended release containing viloxazine hydrochloride at a strength of 200 mg/1. Manufactured by Supernus Pharmaceuticals, Inc.

Key Facts

Brand Name
QELBREE
Generic Name
viloxazine hydrochloride
NDC Code (Package)
17772-133-07
NDC Code (Product)
17772-133
Manufacturer
Supernus Pharmaceuticals, Inc
Strength
200 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
NDA211964
Marketing Start
04/02/2021

Recall History

No Recall History

View Full Drug Page

QELBREE — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.